Literature DB >> 11169831

Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences.

M Kanematsu1, K Itoh, M Matsuo, Y Maetani, F Ametani, H Kondo, H Kato, H Hoshi.   

Abstract

The purpose of our study was to compare observer performance in the detection of malignant hepatic tumors with ferumoxides-enhanced magnetic resonance (MR) images obtained with proton density-weighted spin-echo (SE), T2-weighted fast SE, T2*-weighted gradient-recalled-echo (GRE), and proton density-weighted echo-planar (EP) sequences. Ferumoxides-enhanced MR images obtained with the four sequences in 50 patients with 92 solid malignant and 64 nonsolid benign lesions were retrospectively analyzed. Image review was conducted on a segment-by-segment basis; a total of 397 liver segments was reviewed separately for solid and nonsolid lesions by three independent readers. Observer performance was evaluated with receiver operating characteristic analysis. Lesion-to-liver contrast-to-noise ratio was higher with SE and EP than with GRE and fast SE images for solid lesions (P < 0.05), and higher with fast SE and SE than with GRE images for nonsolid lesions (P < 0.01). Proton density-weighted SE and T2-weighted fast-SE images were superior to T2*-weighted GRE and proton density-weighted EP images for detection of malignant hepatic tumors. T2-weighted fast SE images were the best for detection of nonsolid lesions. T2-weighted fast SE images that were comparable to proton density-weighted SE images for solid tumor detection, that were the best for nonsolid lesion detection, and that had an acquisition time of one third to half of that of SE imaging may be able to replace SE images for ferumoxides-enhanced liver imaging.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169831     DOI: 10.1002/1522-2586(200102)13:2<249::aid-jmri1036>3.0.co;2-c

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

1.  Percentage of signal intensity loss for characterisation of focal liver lesions in patients with chronic liver disease using ferucarbotran-enhanced MRI.

Authors:  C-T Chou; R-C Chen; W-T Chen; J-M Lii
Journal:  Br J Radiol       Date:  2010-04-22       Impact factor: 3.039

2.  Composite MR Contrast Agents for Conditional Cell-Labeling.

Authors:  Matthew Marzelli; Krisztina Fischer; Young Beom Kim; Robert V Mulkern; Seung-Schik Yoo; Hyunwook Park; Zang-Hee Cho
Journal:  Int J Imaging Syst Technol       Date:  2008-06-13       Impact factor: 2.000

3.  Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.

Authors:  Jeong Min Lee; Chong Soo Kim; Ji Hyun Youk; Mi Suk Lee
Journal:  Korean J Radiol       Date:  2003 Jan-Mar       Impact factor: 3.500

4.  Simultaneous detection of hepatocellular carcinoma and vessel thrombus by using SPIO-enhanced B-TFE with the T2 preparation pulse technique.

Authors:  Masayuki Kanamoto; Tosiaki Miyati; Kazuki Terashima; Kei Katahira; Ryoji Ida; Daisaku Suga; Nobukazu Fuwa
Journal:  Radiol Phys Technol       Date:  2017-02-03

5.  Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences.

Authors:  Seung Hoon Kim; Dongil Choi; Jae Hoon Lim; Won Jae Lee; Hyun Jung Jang; Hyo Keun Lim; Soon Jin Lee; Jae Min Cho; Seung Kwon Kim; Gab Chul Kim
Journal:  Korean J Radiol       Date:  2002 Apr-Jun       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.